Seglitide

N/A

Report date: 2026/01/27 17:54:56

Base Information

Drug NameSeglitide
Drug Alias NameSeglitide acetateL-363586MK-678L363586MK678
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionSomatostatin receptor 2 agonists
TargetsSomatostatin receptor 2
Therapy Area/IndicationsDiabetic RetinopathyStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsDiabetic RetinopathyStomach Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A